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Shigella invasion of its human host is assisted
by T3SS-delivered effector proteins. The OspG
effector kinase binds ubiquitin and ubiquitin-loaded
E2-conjugating enzymes, including UbcH5b and
UbcH7, and attenuates the host innate immune
NF-kB signaling. We present the structure of OspG
bound to the UbcH7Ub conjugate. OspG has amin-
imal kinase fold lacking the activation loop of regula-
tory kinases. UbcH7Ub binds OspG at sites remote
from the kinase active site, yet increases its kinase
activity. The ubiquitin is positioned in the ‘‘open’’
conformation with respect to UbcH7 using its I44
patch to interact with the C terminus of OspG.
UbcH7 binds to OspG using two conserved loops
essential for E3 ligase recruitment. The interaction
of the UbcH7Ub with OspG is remarkably similar
to the interaction of an E2Ubwith a HECT E3 ligase.
OspG interfereswith the interactionofUbcH7with the
E3 parkin and inhibits the activity of the E3.
INTRODUCTION
Shigella is a Gram-negative pathogenic bacterium causing
destruction of the intestinal mucosa and dysentery in humans.
As with other Gram-negative pathogens, such as Salmonella,
pathogenic Escherichia coli, and Yersinia, Shigella utilizes a
type III secretion system (T3SS) (Worrall et al., 2011) to deliver
over 20 effector proteins into host cells (Buchrieser et al., 2000).
These effectors hijack cellular processes of the host to promote
invasion, survival, and proliferation of bacteria (Dean, 2011).
Phosphorylation plays a central role in cellular signaling with
over 500 kinases encoded in mammalian genomes (Manning
et al., 2002). Some T3SS effectors, such as SteC (Salmonella)
(Poh et al., 2008), LegKs (Legionella) (Ge et al., 2009), and
YpkA (Yersinia) (Wiley et al., 2009), show high sequence similarity
to human kinases and were likely acquired via horizontal gene878 Structure 22, 878–888, June 10, 2014 ª2014 Elsevier Ltd All rightransfer. Other T3SS effectors, such as OspG (Shigella) (Kim
et al., 2005; Zhou et al., 2013), NleHs (pathogenic E. coli) (Gao
et al., 2009), SboH (Salmonella), and YspK (Yersinia) (Matsumoto
and Young, 2006) are only distantly related to mammalian
kinases (Kannan et al., 2007). The effector OspG is composed
of a kinase-like domain and an N-terminal T3SS secretion signal
(Kim et al., 2005; Zhou et al., 2013). Using a yeast two-hybrid
system, Kim et al. (2005) identified the ubiquitin-conjugating
enzymes (E2s) UbcH5b, UbcH5c, UbcH7, UbcH8, UbcH9, and
RIG-B as OspG interactors. Pull-down experiments showed
that binding to OspG was only observed when the E2 was con-
jugated to ubiquitin (Ub). Expression of OspG in HEK293T cells
prevented the proteasome-dependent degradation of phos-
pho-IkBa, the inhibitor of the NF-kB pathway. This effect was
dependent upon the kinase activity of OspG (Kim et al., 2005);
however, the phosphorylation targets of OspG have not been
identified. Kim et al. (2005) hypothesized that the UbcH5bUb
conjugate serves to ‘‘shuttle’’ OspG to the SCFb–TrCP complex
to phosphorylate some of its components and inhibit its activity.
More recently, Zhou et al. (2013) showed that OspG also binds
ubiquitin and polyubiquitin chains and that this binding stimu-
lates its kinase activity.
E2-conjugating proteins are the central enzymes in the ubiqui-
tination pathway. They accept an Ub from an E1 enzyme and
transfer it either directly to a substrate using a scaffolding really
interesting new gene (RING) E3 ligase or via the formation of a
thioester bond with a homologous to E6AP C terminus (HECT)
E3 ligase. The smaller class of RBR E3 ligases uses a hybrid
mechanism that has aspects of both RING and HECT mecha-
nisms (Wenzel et al., 2011). Ubiquitination proceeds in a step-
wise process with the formation of an E1:E2 complex to transfer
Ub from the E1 to an E2 and the formation of an E2:E3 complex
to transfer Ub either directly to a substrate with the help of a
RING E3 or to a HECT E3. Structural studies have revealed
that E2s use similar regions to recruit both the E1 and E3s (van
Wijk and Timmers, 2010). In E2:E3 complexes, the relative posi-
tions of the E2 and Ub (‘‘open,’’ ‘‘closed,’’ or ‘‘backbent’’) are
dictated by the E2:E3 pair (Page et al., 2012). In the HECT E3
NEDD4L:UbcH5bUb complex (Protein Data Bank [PDB] ID
code 3JW0) (Kamadurai et al., 2009) Ub is in the ‘‘open’’ state;
there is little contact between the E2 and Ub, which are in ants reserved
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OspG Effector Kinase Bound to UbcH7Ub Conjugateextended configuration when recruited to the E3. In the RING E3
RNF4:UbcH5AUb (PDB ID code 4AP4) (Plechanovova´ et al.,
2012) and RING E3 BIRC7:UbcH5BUb (PDB ID code 4AUQ)
(Dou et al., 2012) complexes, Ub is in a ‘‘closed’’ conformation;
Ub interacts with a portion of E2 to form a more contiguous sur-
face to recruit the E3.
The observations that OspG is endowed with a kinase activity
and can interact with Ub and several E2Ub conjugates, such
as UbcH7 and UbcH5b, suggest that OspG might interfere
with the ubiquitin-dependent degradation pathway and raise
several questions: (1) are E2Ub conjugates, Ub/poly-Ub, or
both the biologically relevant partners of OspG; (2) how does
the binding of an E2Ub conjugate affect the kinase activity of
OspG and alter the ubiquitination process to prevent activation
of the NF-kB pathway; and (3) what might be the target of the
kinase activity. To address these issues, we determined the
crystal structure of the complex of OspG with the UbcH7Ub
conjugate in the absence and in the presence of an ATP analog.
The structures show that the OspG:UbcH7Ub interface does
not occlude the active site on OspG, providing an explanation
for the observed kinase activity in the presence of the conjugate
or ubiquitin. Affinitymeasurements indicated that OspG interacts
with the UbcH7Ub conjugate 15-fold tighter than with Ub
alone, suggesting that the E2Ub conjugate is the most relevant
cellular binding partner of OspG. In the complex, Ub is in
an ‘‘open’’ position with respect to UbcH7, as observed in the
UbcH5bUb complex associated with the HECT E3 NEDD4L.
Crucially, UbcH7 binds OspG through the same region that
is used to recruit an E3 prior to Ub transfer to a substrate. Using
in vitro ubiquitination assays, we demonstrated that ubiquitina-
tion by the E3 parkin is attenuated in the presence of OspG.
These structural and biochemical results suggest a mechanism
bywhich OspGmight interfere with the ubiquitination machinery.
RESULTS
OspG Preferentially Interacts with the UbcH7Ub
Conjugate
Kim et al. (2005) showed that OspG interacts with several E2-
conjugating enzymes in their Ub-loaded forms only. Recently,
Zhou et al. (2013) showed that OspG also binds Ub. To investi-
gate the interactions between OspG and UbcH7, Ub, and the
UbcH7Ub conjugate, we used (1) a stable E2Ub complex
formed by a disulfide linkage between the C terminus of Ub
(G76C) and the catalytic cysteine (C86) in UbcH7 (Serniwka
and Shaw, 2009) and (2) an OspG protein lacking the N-terminal
25 residues, as this portion of the protein represents the T3SS
secretion signal and is not important for Ub binding or kinase
function (Zhou et al., 2013). To dissect the relative contributions
of UbcH7 and Ub in OspG recruitment, we quantified the interac-
tions of OspG with UbcH7, Ub, and the UbcH7Ub conjugate
using NMR spectroscopy, isothermal titration calorimetry (ITC),
and size-exclusion chromatography (SEC).
Initial NMR experiments were used to monitor the interaction
of Ub and UbcH7 within the UbcH7Ub conjugate, in which
only UbcH7 was 15N labeled. The 1H-15N HSQC spectrum of
UbcH7 within the conjugate showed that only the amide reso-
nances for residues Cys86 and Leu87 were shifted with respect
to their positions in UbcH7 alone (Figure S1A available online),Structure 22,indicating that the UbcH7Ub complex is intact. The lack of
obvious changes in the remainder of the UbcH7 spectrum in
the UbcH7Ub conjugate also showed that minimal contacts
exist between the E2 and Ub in solution. Addition of OspG to
UbcH7Ub resulted in a significant broadening of a large num-
ber of signals, indicative of the formation of a complex between
OspG and UbcH7Ub (46.2 kDa). Similar experiments were per-
formed using 15N-labeled UbcH7 or 15N-labeled Ub to examine
the individual interactions of each of these proteins with OspG.
Addition of unlabeled OspG to 15N-labeled UbcH7 revealed
minor changes in chemical shifts, indicative of a very weak inter-
action. In contrast, addition of unlabeled OspG to 15N-labeled
Ub resulted in shifting or broadening of several resonances,
including Thr7, Leu8, Arg48, Gln49, His68, Leu69, and Val70
(Figure S1B), identifying an interaction site near the classic I44
patch of ubiquitin and confirming the interaction of OspG with
Ub observed previously (Zhou et al., 2013).
The strength of the interaction betweenOspGandUbcH7Ub,
Ub, and UbcH7was quantified using isothermal titration calorim-
etry. The interaction between OspG and UbcH7Ub displayed
a dissociation constant Kd of 580 ± 20 nM at 25
C. In contrast,
the interactions of OspG with Ub (Kd 9 ± 0.4 mM) and UbcH7
(Kd 90 mM) were about 15 and 150 times weaker (Figure 1).
These results were confirmed by size-exclusion chromatog-
raphy, which was able to detect the complex of OspG with the
UbcH7Ub conjugate, but not with UbcH7 or Ub alone. Addition
of a reducing agent to theOspG:UbcH7Ub complex prior to gel
filtration caused OspG, UbcH7, and Ub to elute as separate
peaks (Figure S2). Together, these results demonstrated a strong
preference for the recruitment of OspG to an E2-Ub conjugate
rather than to individual Ub or UbcH7 components.
The Structure of the OspG:UbcH7Ub Complex
OspG Structure
The structure of the OspG:UbcH7Ub complex was determined
with and without a nucleotide analog (Figure 2; Table 1). As ex-
pected from previous biochemical data (Kim et al., 2005; Zhou
et al., 2013), OspG has a kinase-like fold, although it lacks
several elements of the canonical kinases (Figures 2B and 2C).
Its structure represents a minimal kinase domain, comprising
segments I–VII and IX of the classical regulatory kinase fold
(Hanks and Hunter, 1995). In the complex, OspG consists of
two subdomains with an active center situated in a deep cleft
between them. The N-terminal subdomain (N-lobe, residues
26–101) is built of a five-stranded b sheet (b1–b5) and a helix
a1 (segments I–IV) (Figure 2B) and includes a Gly-rich P loop
(segment I) with the sequence I33GQGSTAEI41, the invariant
Lys53 (segment II), and Glu72 (helix a1, frequently called a helix
C, segment III). The P loop participates in ATP binding, whereas
Lys53 participates in the orientation of ATP b- and g-phosphate
groups. The carboxyl group of Glu72 forms a hydrogen bond
with the amine group of Lys53, properly positioning this side
chain for catalysis. The C-terminal subdomain (C-lobe, residues
102–196) has a mixed a/b fold with two b strands (b6, b7), two
long helices (a3, a4), and two one-turn helices (a2, a30) (seg-
ments V–VII, IX) (Figure 2B). It contains the ‘‘catalytic loop’’
(segment VIB) with the sequence HYD138LNTGN143 differing
from the consensus sequence H/YRDX
K/XXXN of human kinases
(Hanks and Hunter, 1995). The conserved DFG motif in segment878–888, June 10, 2014 ª2014 Elsevier Ltd All rights reserved 879
Figure 1. Isothermal Titration Calorimetry Analysis for OspG Binding to Ub, UbcH7, and UbcH7Ub
(A) Isotherm graph for OspG and Ub.
(B) Isotherm graph for OspG and UbcH7.
(C) Isotherm graph for OspG and UbcH7Ub.
The upper panels present raw data, and the lower panels present the integrated heat changes for a single-site binding model. Data were collected in buffers
containing 100 mM Na H2PO4, 100 mM NaCl (pH 7.5) at 25
C.
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OspG Effector Kinase Bound to UbcH7Ub ConjugateVII is replaced in OspG by the D157FR sequence. Segment VIII,
corresponding to the activation loop in regulatory kinases, is
significantly shorter and is followed by the C-terminal helix a4
(also called a helix F, segment IX).
A comparison with the structures of typical regulatory kinases
indicates that OspG assumes an active conformation in the com-
plex; the seven catalytically important residues (Gly34, Gly36,
Lys53, Glu72, Asp138, Asn143, and Asp157) superimpose on
the corresponding residues of the active state of protein kinase
A (PKA; PDB ID code 1ATP) with a root-mean-square deviation
(rmsd) of 0.8 A˚ for all Ca atoms (Figure 2C). Additionally, the
conformation of the conserved D157FR motif is also typical of
the active state of the regulatory kinases. Moreover, the so-
called ‘‘regulatory’’ (R) and ‘‘catalytic’’ (C) spines, present only
in the active states of regulatory kinases (Kornev et al., 2006,
2008), are fully assembled in OspG (Figure S3A). The structure
of OspG is similar to the recently determined structures of
NleH1/2 kinase domains with the exception of the placement
of helix a4 in segment IX (Grishin et al., 2014) (Figure S3B). The
superposition of these molecules results in an rmsd of 1.28 A˚
for 115 Ca atoms out of 168 (excluding a4 and a few loops).
ATP Binding and the Active Site
Comparison of OspG:UbcH7H7 complexes obtained in the
absence and in the presence of AMPPNP showed that the nucle-
otide binding proceeds with minimal structural adjustments—
0.3 A˚ rmsd for all atoms of the seven key active site residues
(excluding Asp157 sidechain that adopts different conformation)
(Figure 2D). The adenine moiety binds within a conserved hydro-
phobic pocket composed of Ile41, Leu51, Phe76,Met98, Val101,
Leu145, and Ile156, with an amino group pointing toward the880 Structure 22, 878–888, June 10, 2014 ª2014 Elsevier Ltd All righbottom of the pocket and forming a hydrogen bond with the
backbone carbonyl of Leu99, whereas the adenine N7 hydrogen
bonds to the amide of Asp157 through a bridging water.
Although OspG differs in four out of seven residues defining
the adenine pocket from PKA, the hydrophobicity of the pocket
is well preserved and the nucleotide binding mode is very similar
in the two proteins. The a-phosphate in AMPPNP makes a
hydrogen bond with Lys53, an essential residue for the kinase
activity (Kim et al., 2005; Zhou et al., 2013), whereas the g-phos-
phate interacts with Asn143 and Asp157. The Mg2+ ion is coor-
dinated in a tetragonal bipyramid with the carboxyl group of
Asp157 and several water molecules and corresponds to the
primary Mg2+ atom in PKA. The g-phosphate in OspG occupies
the position of the secondary Mg2+ in PKA.
Interaction of Ub with OspG
The structure of OspG:UbcH7Ub shows atomic details of the
adaptation of a minimal-fold kinase to the binding of a relatively
large molecular complex through multiple interfaces. Mutational
analysis identified the C terminus of OspG as essential for Ub
binding (Zhou et al., 2013); however, the detailed molecular
nature of this interaction has not been determined. Our structural
analysis shows that Ub binds to a hydrophobic depression be-
tween a3 and a4 near the C terminus of OspG. This depression
is created through a different placement of a4 (helix F, segment
IX) in OspG with respect to its counterparts in PKA (Figure 2C)
and NleH1/2 (Figure S3B). Further, whereas the C terminus of
a4 is in a similar position to that in PKA, anchored via Phe187
and Leu190 to the C-spine of OspG, the N-terminal part is shifted
by 7 A˚ and occupies a position taken by the activation loop in
the active state of PKA. The repositioning of these two helices ints reserved
Figure 2. Structure of OspG:UbcH7Ub Complex
(A) The view of the complex corresponds to a standard kinase orientation with
the helical domain at the bottom, sheet domain at the top, and the substrate
binding site on the right. The proteins are shown in cartoon form. OspG is
colored in wheat; UbcH7 is in green; and Ub is in blue. The solvent-accessible
surface is shown as semitransparent. The ATP analog AMPPNP (red) is shown
in the active site of OspG. The Cys86 (UbcH7) and Cys76 (Ub) residues
participating in the disulfide bond formation are shown as spheres.
(B) OspG cartoon drawing with marked secondary structures. The molecule is
painted in rainbow colors, from blue at the N terminus to red at the C terminus.
(C) Comparison of the OspG structure with the canonical regulatory kinase fold
of protein kinase A (PKA). OspG is colored magenta, whereas PKA is colored
according to its core (yellow), activation loop (green), N-terminal extension
(cyan), and C-terminal extension (blue) regions. The AMPPNP nucleotide
(shown as sticks) marks the location of the active site.
(D) The active-site region of OspG with (white) and without (green) nucleotide.
Only Asp157 changes orientation upon nucleotide binding.
Table 1. Summary of Data Collection and Refinement Statistics
Data Set OspG+UbcH7Ub
OspG+UbcH7
Ub+AMPPNP
Space group P212121 P212121
a,b,c (A˚) 67.3, 84.1, 85.4 67.4, 84.7, 85.9
a,b,g () 90, 90, 90 90, 90, 90
Wavelength (A˚) 0.97949 0.97949
Resolution (A˚) 50.0–1.87 50.0–2.0
Last resolution shell (A˚) 1.9–1.87 2.03–2.0
Observed hkl 449,840 242,414
Unique hkl 40,758 33,962
Completeness (%)a 100.0 (100.0) 99.9 (100.0)
Redundancya 11.0 (11.1) 7.1 (7.0)
Rsyma 10.0 (>1.00) 9.4 (>1.00)
I/(sI)a 30.5 (2.0) 25.5 (1.98)
Rwork 20.27 20.24
Rfree (%hkl) 24.29 (5) 24.3 (5)
Wilson B (A˚2) 35.6 35.07
B-Factor A˚2 (no. of atoms)
Protein 55.7 (3,256) 43.4 (3,285)
Solvent 47.2 (237) 33.4 (212)
Ligand NA 29.2 (33)
Ramachandran Plot
Allowed (%) 97.67 97.12
Generous (%) 2.07 2.62
Disallowed (%) 0.26 0.26
Rmsd
Bonds (A˚) 0.006 0.008
Angles () 0.98 1.18
PDB ID codes 4Q5E 4Q5H
aThe information for the last shell of resolution is given in parentheses.
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Structure 22,OspG, relative to that observed in other kinases, creates the hy-
drophobic depression used as the focal point for Ub binding. Ub
contacts OspG through residues from its four b strands and the
loop following b4. The turn between b3 and b4 (Ala46-
Gly47-Arg48) protrudes into the center of the OspG depression
created by a3 and a4 approaching His136 (R-spine) in the
HYD138LNTGN143 motif of OspG (Figure 3A). The Ub residues
Leu8, Ile44, and Val70 used to recruit OspG, form a hydrophobic
patch well known for involvement in Ub binding to other proteins
(Beal et al., 1998; Sloper-Mould et al., 2001; Lee et al., 2006).
Other Ub residues contacting OspG, such as Arg48, Gln49,
Glu51, Arg54, Ser57, Asp58, and Tyr59, have a more polar na-
ture. For example, hydrogen bonds from Glu51 in Ub are formed
to Asn130 and Tyr162 in OspG, whereas Tyr59 in Ub forms
herringbone contacts to Tyr165 and Tyr166 in OspG. In addition,
Arg48 in Ub (Lys48 in wild-type Ub) forms a salt bridge with
Asp177 in OspG (Figure S4A).
Interaction of OspG with UbcH7
Whereas Ub binds to the C-lobe of OspG away from the OspG
substrate binding site, UbcH7 contacts both the N- and C-lobes
on the backside of OspG (Figure 2A). The OspG surface binding
UbcH7 is relatively flat, hydrophobic in the center (Phe79, Tyr80,878–888, June 10, 2014 ª2014 Elsevier Ltd All rights reserved 881
Figure 3. The OspG Interface with UbcH7
and Ub
(A) Surface of OspG, colored gray for hydrophobic
residues and wheat elsewhere, with cartoon
model of Ub. A deep cavity between the C-termi-
nal helices (a3, a4) of OspG (red) and the
‘‘activation loop’’ (green) is the focal point of the
interaction with the b3-b4 turn of Ub (magenta)
extending into this cavity. Additional interactions
are provided by the short a helix (red) and b
strands (yellow) of Ub.
(B) Contacts between OspG (wheat) and UbcH7
(green). The UbcH7 helix (aH1) and two loops (L4,
L7) contacting OspG are painted magenta.
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OspG Effector Kinase Bound to UbcH7Ub ConjugateLeu99, Pro102, and Phe154), and hydrophilic on the edges
(Asp47, Ser49, Asp82, Glu83, Lys128, Glu149, and Ser150)
(Figure 3B). This OspG surface is formed by three loops: the
loop between a1 (helix C) and b4, the loop following b5, and
the turn between hairpin strands b7-b8. The hydrophobic char-
acter of this interface in OspG is not present in the structurally
closely related NleH kinases (Grishin et al., 2014).
UbcH7 residues in contact with OspG belong to the N-terminal
a helix (aH1), loop 4 (L4), and loop 7 (L7) defined for E2s (vanWijk
and Timmers, 2010) (Figures 3B and 4). Residues in these re-
gions of UbcH7 are highly conserved among E2s, which might
account for the binding of OspG to a number of E2s (Kim et al.,
2005). Furthermore, these residues are typically used to recruit
RING- andHECT-type E3s (Huang et al., 1999; vanWijk and Tim-
mers, 2010; Budhidarmo et al., 2012). Specifically, the UbcH7
interface with OspG involves a pair of basic residues (Arg5,
Arg6) in aH1 and hydrophobic interactions in which Pro62 and
Phe63 (L4), and Lys96, Pro97, and Ala98 (L7) contact OspG res-
idues Phe79, Tyr80, Leu99, Pro102, and Phe154. Several
hydrogen bonds are also formed at the edges of the interface,
including a salt bridge between Arg5 in UbcH7 and Asp47 in
OspG.
The structure shows that UbcH7Ub bind to two independent
sites leaving the active site of OspG accessible not only to ATP882 Structure 22, 878–888, June 10, 2014 ª2014 Elsevier Ltd All rights reservedbut also to potential substrate(s). The co-
valent connection between UbcH7 and
Ub increases the cooperativity between
the sites as demonstrated by the 15-fold
increased affinity of OspG for UbcH7Ub
as compared to Ub. However, little inter-
action between the extended C terminus
of Ub and OspG is evident from the struc-
ture, indicating that residues involved in
the UbcH7Ub linkage do not contribute
to the binding affinity. The observation
that both the E2 and Ub are involved in
the recruitment of OspG is reminiscent
of the mechanism used by different
E2Ub conjugates to recruit their
cognate E3s. In the OspG:UbcH7Ub
structure, the Ub in UbcH7Ub is disen-
gaged from UbcH7 with a limited contact
surface, in agreement with the 1H-15N
HSQC spectrum of the UbcH7Ub com-
plex showing a limited interaction between the two proteins (Fig-
ure S1A). This arrangement is similar to the ‘‘open’’ configuration
adopted by UbcH5bUb in complex with NEDD4L, in which Ub
is recruited by theC-lobe of theHECT E3 (Kamadurai et al., 2009)
(Figure 4). Superposition of the E2Ub components in the OspG
and NEDD4L complexes shows that the two arrangements are
very similar (Figures 4 and S4B). In contrast, comparison of the
UbcH7Ub configuration with that of UbcH5a-Ub in complex
with the RING E3 RNF4 shows little similarity in the Ub posi-
tioning. In this structure, the UbcH5aUb adopts a ‘‘closed’’
conformation, in which Ub is in contact with both the E2 and
RNF4 (Plechanovova´ et al., 2012). These observations suggest
that OspG might interfere with UbcH7-mediated ubiquitination
by recruiting UbcH7Ub through a HECT-like structural mimic.
The OspG:UbcH7Ub Complex Exhibits Increased
Kinase Activity
The structure of theOspG:UbcH7Ubcomplex unequivocally in-
dicates that binding of the UbcH7Ub conjugate to OspG does
not occlude the kinase active site or the substrate binding site
of OspG and should not interferewith the ability of OspG to phos-
phorylate substrates. It was shown previously that binding of Ub
toOspGmildly activates theOspGkinaseactivity towardhistones
at 30C in vitro (Zhou et al., 2013). We investigated the kinase
Figure 4. The UbcH7Ub Conjugate Adopts an ‘‘Open’’ Conformation upon Binding to OspG
(A) Ribbon diagram showing OspG bound to UbcH7Ub. Residues in UbcH7 present in helix aH1 (Arg5) and loops L4 (Phe63) and L7 (Lys96, Pro97) and Ub
(Leu8, Ile44 and Arg48) that are important for the interaction with OspG are highlighted in red. The UbcH7Ub conjugate is oriented in an ‘‘open’’ conformation.
(B) Ribbon diagram showing UbcH5bUb in the ‘‘open’’ conformation when bound to the HECT E3 NEDD4L (PDB ID code 3JW0) showing residues in helix aH1
and loops L4 and L7 of UbcH5b that are important for the interaction. In NEDD4L, only residues 734–796 and 872–949 are shown for clarity.
(C) Ribbon diagram showing UbcH5aUb in the ‘‘closed’’ conformation when bound to the RING E3 RNF4 (PDB ID code 4AP4). Only residues 131–195 from
RNF4 are shown. Panels were prepared by superimposing the E2 structures of UbcH7, UbcH5a, and UbcH5b in PyMOL.
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OspG Effector Kinase Bound to UbcH7Ub Conjugateactivity of OspG in the presence of the UbcH7Ub conjugate or
Ub, using histone H1 as a substrate. The presence of Ub stimu-
lated the activity 8-fold, whereas the presence of the
UbcH7Ub conjugate stimulated the activity 20-fold (Figure
5). On the other hand, UbcH7 had no effect on OspG activity.
These results demonstrated that the kinase activity of OspG
was preserved and even largely increased in the OspG:
UbcH7Ub complex.
UbcH7 Binding to OspG Is Important for Stimulation of
the Kinase Activity
Results presented above suggested that binding of both Ub
and UbcH7 contribute to OspG activation. Zhou et al. (2013)
demonstrated that mutations in the Ub binding site of OspG
abolished activation of OspG kinase activity by Ub. To investi-
gate the importance of UbcH7 binding on kinase activation,
we constructed the OspG mutants F154R and L99R/P102E
affecting residues at the binding surface for UbcH7. In the
OspG:UbcH7Ub structure, residues L99 and P102 (loop
following b5 in the N-lobe) and F154 (b7 in the C-lobe) interact
with the L4 and L7 loops of UbcH7 (Figure S4C). As compared
to wild-type OspG, the mutants showed similar gel filtration pro-
files (FigureS5A) andcircular dichroismspectra (FigureS5B). The
OspG-F154R andOspG- L99R/P102Emutants exhibited a lower
kinase activity than did wild-type OspG, and this activity was still
stimulated by Ub (Figure 5). In the presence of the UbcH7Ub
conjugate, only OspG-F154R could be activated, resulting in
activity still significantly smaller that the wild-type OspG.
OspG Inhibits the Ubiquitination Activity of the E3Parkin
In the OspG:UbcH7Ub complex, OspG engages UbcH7Ub
residues involved in the interaction of this UbcH7 with E3s, sug-
gesting that OspG might compete with E3s for the binding to
UbcH7 and thereby interfere with the activity of the E3. Further-
more, thedissociationconstant (580nM)of theOspG:UbcH7Ub
complex reflects a tighter association as compared to the one
typically observed for E2-E3 interactions, such as for the inter-
action of the E3 E6AP with UbcH7Ub (dissociation constant ofStructure 22,6.5 mM) (Purbeck et al., 2010) or the E3 parkin with UbcH7 (disso-
ciationconstantof 4.7mM) (Regnstro¨met al., 2013). To investigate
whetherOspGmight inhibit the activity of anE3,wemeasured the
autoubiquitination of the E3 parkin in the presence of E1, UbcH7,
Ub, and various amounts of OspG (Figure 6). The presence of
OspG led to a strong decrease in the appearance of ubiquitinated
parkin molecules and the ubiquitination activity of parkin was
almost completely inhibited at an UbcH7:OspG molar ratio of
1:1. To test the importance of the OspG-UbcH7 interaction on
the inhibition of the parkin activity by OspG, we used the OspG
variants OspG-F154R and OspG-L99R/P102E that impair the
interaction between OspG and UbcH7. These OspG variants
were unable to inhibit the autoubiquitination activity of parkin
(Figure 6). These results indicated that OspG can inhibit the ubiq-
uitination activity of an E3 and that the binding site of UbcH7 onto
OspG is necessary for this inhibition.
Recruitment of theUbcH7UbConjugate ProtectsOspG
from Degradation by the Proteasome
To investigate the contribution of UbcH7 binding onto OspG to
the activity of OspG within host cells, plasmids encoding Myc-
tagged OspG-WT, OspG-L99R, OspG-P102E, OspG-L99R/
P102E, or OspG-F145R were transfected into HEK293T cells.
Steady-state amounts of recombinant proteins were analyzed
by SDS-PAGE and immunoblotting using anti-Myc antibodies.
Unexpectedly, all OspG variants were detected in much lower
amounts as compared to wild-type OspG (Figure 7). To investi-
gate whether decreased amounts of OspG variants were due
to the increased degradation of these proteins, transfected cells
were treated with the proteasome inhibitor MG132 for 3 hr.
MG132 treatment led to a slight increase in the amount of wild-
type OspG and to a much larger increase in the amounts of all
OspG variants (Figure 7). These results strongly suggest that,
as compared to wild-type OspG, variants that do not bind
UbcH7 have an increased susceptibility to degradation. As a
consequence, OspG variants did not prevent phospho-IkBa
degradation upon stimulation of transfected cells with TNFa to
induce the NF-kB pathway (data not shown).878–888, June 10, 2014 ª2014 Elsevier Ltd All rights reserved 883
Figure 5. Activity and Activation of OspG and OspG Mutants at 28C Using [g-32P]ATP
(A) The nonreducing SDS-PAGE for OspG. Lanes: 1, histone H1 (5 mg); 2, histone H1 (5 mg) + OspG (1.3 mg), EDTA; 3, histone H1 (5 mg) + UbcH7-Ub (5.4 mg) +
OspG (1.3 mg), EDTA; 4, histone H1 (5 mg) + OspG (1.3 mg); 5, histone H1 (5 mg) + UbcH7 (1.2 mg) + OspG (1.3 mg); 6, histone H1 (5 mg) + Ub (0.56 mg) + OspG
(1.3 mg); 7, histone H1 (5 mg) + UbcH7-Ub (1.8 mg) + OspG (1.3 mg).
(B) The nonreducing SDS-PAGE for OspG(L99R/P102E) and OspG(F154R) mutants. Lanes: 1, histone H1 (5 mg); 2, histone H1 (5 mg) + UbcH7-Ub (5.4 mg) +
OspG(L99R/P102E) (1.3 mg), EDTA; 3, histone H1 (5 mg) + OspG(L99R/P102E) (1.3 mg); 4, histone H1 (5 mg) + UbcH7 (3.6 mg) + OspG(L99R/P102E) (1.3 mg); 5,
histone H1 (5 mg) + Ub (1.7 mg) + OspG(L99R/P102E) (1.3 mg); 6, histone H1 (5 mg) + UbcH7-Ub (5.4 mg) + OspG(L99R/P102E) (1.3 mg); 7, histone H1 (5 mg) +
OspG(F154R) (1.3 mg); 8, histone H1 (5 mg) + UbcH7 (3.6 mg) + OspG(F154R) (1.3 mg); 9, histone H1 (5 mg) + Ub (1.7 mg) + OspG(F154R) (1.3 mg); 10, histone H1
(5 mg) + UbcH7-Ub (5.4 mg) + OspG(F154R) (1.3 mg).
(C) Radioscan of the gel in (A).
(D) Radioscan of the gel in (B).
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The OspG kinase is one of20 Shigella effectors contributing to
host invasion and subversion of cellular functions. One of the
effects of OspG is to dampen activation of the NF-kB pathway
by preventing the degradation of phospho-IkBa; however, the
sequence of events leading to this effect is not elucidated.
OspG was shown to bind a number of E2s and to associate pref-
erentially to E2Ub conjugates, rather than to E2s alone (Kim
et al., 2005). In addition, OspG binding to Ub and poly-Ub chains
has been reported (Zhou et al., 2013), and the kinase activity of
OspG (Kim et al., 2005) was shown to be stimulated by Ub
(Zhou et al., 2013). Results presented therein on the association
of OspG with an UbcH7Ub conjugate, the increased kinase
activity of the complex, and the inhibitory effect of OspG on
the activity of the E3 parkin, together with the elucidation
of the structure of the OspG:UbcH7Ub complex, shed light
on the mode of action of this effector.
OspG does not conform to typical eukaryotic kinases (Kannan
et al., 2007) and is structurally most closely related to Rio (Lar-
onde-Leblanc et al., 2005) and Bud32 (Hecker et al., 2008)
atypical kinases. It contains only the most basic elements of
the kinase fold and is much smaller than typical regulatory
kinases. Although the shorter ‘‘activation loop’’ of OspG contains
three Tyr residues and one Thr residue, these residues are
either facing away from the active site or are located too far
away to provide an effective regulation of the kinase activity
by phosphorylation. Indeed, the conformation of OspG in the
OspG:UbcH7Ub complex closely resembles the active confor-
mation of regulatory kinases.
Considering the active site as the front of OspG, binding of
UbcH7Ub involves the side and back surfaces of OspG, leav-884 Structure 22, 878–888, June 10, 2014 ª2014 Elsevier Ltd All righing the active site accessible for potential substrates. The inter-
face with Ub is centered on a deep depression formed between
a3 and a4 of OspG and engages two regions of Ub surrounding
residues Ile44 and Tyr59. The former is known to participate in
Ub binding to other proteins (Beal et al., 1998; Sloper-Mould
et al., 2001; Lee et al., 2006). Comparison with the structure of
PKA indicates that the displacement of the N-terminal end of
a4 in OspG is crucial for the formation of the Ub binding depres-
sion. Zhou et al. (2013) showed that mutations L190D/L191D
abolished Ub binding and proposed that these residues interact
with the Ile44 patch on Ub. However, the structure of OspG:
UbcH7Ub indicates that these two Leu residues are located
at the last turn of a3; they are not in contact with Ub, but rather
face the interior of the molecule and interact with hydrophobic
residues in a2. Their replacement by acidic residuesmight cause
a readjustment of a2 and a3, thereby distorting the Ub binding
interface of OspG. UbcH7 interacts with OspG through a sur-
face encompassing residues in L4 (Pro62, Phe63) and L7
(Lys96, Pro97, Ala98) of UbcH7. Upon interaction with OspG,
UbcH7Ub adopts an ‘‘open’’ conformation similar to the one
observed for UbcH5b-Ub interacting with the HECT E3 ligase
NEDD4L (Kamadurai et al., 2009). Both the 3D structure and af-
finity measurements of OspG for UbcH7Ub, UbcH7, and Ub
suggest that the E2Ub conjugate might be the most relevant
partner of OspG within host cells.
We confirmed that the kinase activity of OspG is enhanced
in the presence of Ub (Zhou et al., 2013) and showed that
this activity is even more stimulated in the presence of the
UbcH7Ub conjugate. To investigate the respective contribu-
tions of UbcH7 and Ub binding to OspG on the stimulation of
the kinase activity, we used the OspG variants L99R/P102E
and F154R altered in the UbcH7 binding site. The circularts reserved
Figure 6. Inhibition of Parkin Activity by OspG
(A) Western blot analysis of autoubiquitination assays of DUblD parkin using
anti-parkin (top) and anti-His (bottom) antibodies from 4%–15% SDS PAGE.
On each blot, the first two lanes contain either Ub (Ub) or parkin (DUblD) alone.
All other lanes contain E1, ATP, and reactants indicated above the lanes.
Amounts of OspG are equivalents relative to UbcH7. Autoubiquitination
products [Ub]n detected using anti-parkin or anti-His (recognizing His-Ub)
antibodies are indicated.
(B) Coomassie-stained 8% Bis-Tris SDS PAGE as described in (A).
Figure 7. Expression of Wild-Type and Variant OspG Proteins in
Transfected HEK293T Cells
Cells transfected by pRK5-myc (vector) or pRK5-myc-OspG-encoding wild-
type OspG (WT) or its derivatives harboring the indicated replacements were
(+) or not () treated with the proteasome inhibitor MG132 (MG132 tx). After
3 hr, samples were analyzed by SDS-PAGE and immunoblotting using a serum
raised against the Myc tag.
Structure
OspG Effector Kinase Bound to UbcH7Ub Conjugatedichroism spectra (Figure S5B) of these two variants were similar
to that of wild-type OspG, suggesting that the structure of the
soluble proteins was not affected by these replacements; as in
the case of wild-type OspG, their activity was increased in the
presence of Ub. The effect of the UbcH7Ub conjugate on the
activity of the L99R/P102E mutant was reduced to the one
observed with Ub, indicating that the UbcH7 binding site on
OspG was indeed disrupted in this variant. Stimulation of the ki-
nase activity of the OspG-F154R mutant by UbcH7Ub was in-
termediate between wild-type OspG and OspG-L99R/P102E,
suggesting that this mutant was still able to interact with the
UbcH7 moiety of the conjugate, albeit less strongly than wild-
type OspG. Indeed, Phe154 of OspG stacks against Phe63 of
UbcH7, and it is possible that the aliphatic side chain of the
Arg residue in F154R mutant can still provide an interactive sur-
face for Phe63 in UbcH7. These results are evidence that bindingStructure 22,of the UbcH7 moiety in the UbcH7Ub conjugate is essential for
the full stimulation of the kinase activity of OspG. The Ub binding
surface on OspG is away from the kinase active site, and the
structure of the OspG:UbcH7Ub complex provides no direct
explanations for activation of OspG by Ub or the UbcH7Ub
conjugate. However, considering the effect of OspG mutations,
it seems likely that structural changes might occur in OspG
upon binding of the UbcH7Ub conjugate (or Ub). The confor-
mation of OspG in solution would not be catalytically active,
and an adjustment in the relative orientations of the N- and
C-terminal lobes might have to occur to get the active form
observed in the crystal structure. Indeed, in the structure of the
OspG:UbcH7Ub complex, OspG is in an active conformation
and binds the nucleotide without any further conformational
adjustment. Insertion of the turn located between b3 and b4 of
Ub into the depression in OspG surface (Figure 3A) might be
involved in the spatial reorganization of the catalytic site upon
binding of UbcH7Ub.
Residues of UbcH7 interacting with OspG are conserved in
various E2s and are involved in the interaction of E2s with their
E3 partners (Budhidarmo et al., 2012). This observation sug-
gested that OspG might interfere with the activity of E3s by
competing with E3s for the recruitment of E2-Ub conjugates.
Indeed, at a 1:1 molar ratio of OspG:UbcH7, the autoubiquitina-
tion activity of parkin was strongly inhibited. Furthermore, the
effects of the replacements F154R and L99R/P102E on the
inhibition of parkin activity mirrored the effects these replace-
ments had on the stimulation of the kinase activity of OspG,
i.e., a partial effect for F154R and a complete loss for L99R/
P102E. Transfection of human cells by plasmids expressing
wild-type OspG and variants affected in the UbcH7 binding
site showed that these variants were degraded more rapidly
than wild-type OspG. This result suggests that OspG in its
monomeric form is more prone to degradation than in its
UbcH7Ub-associated form and that binding of the E2Ub
conjugate stabilizes OspG in the intracellular environment.
The difference in viability of OspG associated or not with
E2Ub in the intracellular environment supports the above
proposal that OspG might exist in two conformations. Because
of their premature degradation, OspG variants unable to bind
UbcH7 did not prevent phospho-IkBa degradation upon stimu-
lation of transfected cells with TNFa.
In conclusion, we showed that (1) the E2Ub conjugate is the
likely biological partner of OspG, because the affinity of OspG to
the conjugate is much higher than the affinity to Ub alone; (2)
binding of UbcH7Ub involves two nonoverlapping surfaces878–888, June 10, 2014 ª2014 Elsevier Ltd All rights reserved 885
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OspG Effector Kinase Bound to UbcH7Ub Conjugateon OspG and, in this complex, the OspG active site is accessible
to potential substrates; (3) binding of UbcH7Ub increases the
kinase activity of OspG, possibly by stabilizing a more active
conformation that is also less prone to degradation in the intra-
cellular environment; and (4) Kim et al. (2005) proposed that
the E2Ub conjugate was used by OspG as a ‘‘delivery vehicle’’
to be targeted to and phosphorylate the E3 SCFb-TrCP complex
involved in phospho-IkB ubiquitination (Yaron et al., 1998). How-
ever, this mode of action appears unlikely because the region of
the E2 binding to the E3 SCFb-TrCP complex (Zheng et al., 2002) is
the same that binds to OspG and, as shown here for the E3 par-
kin, OspG, and SCFb-TrCP would compete for E2Ub conju-
gates. The present discovery that the E2 engages with OspG
through a surface that is similar to that used for its interaction
with both the E1 and the E3s indicates that OspG interferes in
the ubiquitination process, at least in part, by hijacking E2Ub.
EXPERIMENTAL PROCEDURES
Cloning, Mutagenesis, and Protein Expression
The portion of the Shigella flexneri 2a strain 2457T ospG gene-encoding resi-
dues 26–196 was inserted into pMCSG7 (pET21-derivative) using the ligase
independent cloning (LIC) procedure adding a TEV-cleavable His6-tag.
Ub(K48R/G76C) and UbcH7(C17S/C137S) were expressed as previously
described (Merkley et al., 2005; Serniwka and Shaw, 2009). All constructs
were transformed into BL21(DE3)Star (Invitrogen) or BL21(DE3) (Novagen)
cells; bacteria were grown in Terrific broth at 37C until the OD600 reached
0.6 units. Expression was induced with 1 mM isopropyl b-D-1-thiogalactopyr-
anoside for 12–16 hr at 20C. For 15N-labeled proteins, cells were grown in M9
media using 15NH4Cl as the sole nitrogen source as previously described
(Merkley et al., 2005; Serniwka and Shaw, 2009).
Mutations corresponding to F154R and L99R/P102E were introduced using
the QuikChange mutagenesis scheme, yielding OspG-154R and OspG-L99R/
P102E. The Phe154 codon TTC was replaced by the Arg codon CGC; the
Leu99 codonCTGwas replaced by the Arg codonCGG; and the Pro102 codon
CCT was replaced by the Glu codon GAA.
Protein Purification and UbcH7Ub Conjugation
Details for the purification of Ub and UbcH7 have been previously described
(Merkley et al., 2005; Serniwka and Shaw, 2009). The UbcH7Ub conjugate
was obtained following the procedure by Merkley et al. (2005), where the nat-
ural thioester bond between Cys86 in UbcH7 and the carboxylic group of
Gly76 in Ub was replaced by a disulfide bond. To this end, the UbcH7Ub
conjugate was formed between UbcH7(C17S/C137S) and Ub(K48R/G76C)
proteins via mild Cu2+ oxidation (Figures S5C and S5D).
After purification on Ni-NTA beads (QIAGEN), OspG was dialyzed overnight
against 50 mM HEPES and 50 mM NaCl at pH 8.0. The His6-tag was cleaved
with TEV protease using a 30:1 (w/w) ratio and 2 hr incubation at 28C. TEV
protease and uncleaved OspG were removed by reapplication to Ni-NTA
beads. The cleaved OspG was purified through gel-filtration on a Superdex
75 10/300 (GE Healthcare) in 15 mM HEPES, 50 mM NaCl at pH 8.0 with or
without 0.5 mM TCEP. OspG mutants were expressed and purified in the
same way as the wild-type OspG. OspG wild-type was characterized under
reducing conditions by size-exclusion chromatography and dynamic light
scattering. Both methods showed that OspG is monomeric in solution (Fig-
ure S5E). However, in the absence of reducing agent, we also observed the
presence of dimeric disulfide-bridged species (via Cys127; Figure S5E).
The crystallization was conducted under nonreducing conditions by mixing
the purified UbcH7Ub conjugate with the monomeric OspG fraction from
gel filtration performed under nonreducing conditions. The OspG F154R and
L99R/P102E mutants produced sharp peaks on gel filtration at the elution
volume similar to the wild-type OspG (Figure S5A).
Monomeric OspG was incubated with UbcH7Ub (molar ratio 1:1) and
purified using gel filtration on Superdex 75 in the same buffer. The formation
of the OspG:UbcH7Ub complex was monitored by gel filtration. The effect886 Structure 22, 878–888, June 10, 2014 ª2014 Elsevier Ltd All righof disulfide bond formation on the complex stability was investigated by treat-
ing the mixture with 5 mM DTT for 15 min and followed with gel filtration on
Superdex 75 (Figure S2). For other interaction experiments, OspGwas purified
in the presence of 0.5 mM TCEP.
NMR Spectroscopy
All NMR experiments were collected on a 600 MHz Varian Inova spectrometer
(Biomolecular NMR Facility, University of Western Ontario) equipped with a tri-
ple-resonance probe and x,y,z gradients. 1H-15NHSQC spectra were acquired
using the sensitivity-enhanced method at 25C (Barbato et al., 1992). All
samples were prepared in 100mMNaH2PO4, 100mMNaCl at pH 7.5 and con-
tained 15N-labeled Ub, 15N-labeled UbcH7, or UbcH7Ub in which only the
UbcH7 moiety was 15N-labeled. Assignments for these proteins have been
previously reported (Hamilton et al., 2000; Serniwka and Shaw, 2008). For pro-
tein interaction experiments, duplicate samples were made of the 15N-labeled
protein (100 mM) in the absence and presence of OspG (200 mM). Samples
were then mixed to obtain intermediate ratios. All spectral parameters used
to collect data of a particular 15N-labeled protein ± OspG were identical. Sam-
ples were referenced directly to a DSS internal standard. Data were processed
using 60-shifted cosine bell-weighting functions in the 1H and 15N dimensions
using NMRPipe (Delaglio et al., 1995) and analyzed using NMRView (Johnson
and Blevins, 1994).
Isothermal Titration Calorimetry
All calorimetry experiments were done using a Microcal VP-ITC system (GE
Healthcare) using freshly prepared proteins in 100 mM NaH2PO4, 100 mM
NaCl at pH 7.5. UbcH7, Ub, or UbcH7Ub proteins were titrated into the calo-
rimeter cell containing OspG. Protein concentrations were determined using
amino acid analysis (SPARC BioCentre Amino Acid Facility). All experiments
were completed in triplicate at 25C, and data were analyzed using a single-
site binding model in Origin (OriginLab).
Protein Crystallization
Purified OspG:UbcH7Ub complex was concentrated to 14 mg/ml, and ali-
quots weremixed with 5mMAMPPNP andMg2+. Initial crystals were obtained
by the sitting drop method with ProComplex solutions (QIAGEN). The best
crystals were obtained from 0.1 M MgCl2, 0.1 M HEPES, and 15% PEG
4000 at pH 8.0 and were cryoprotected in 0.1 M MgCl2, 0.1 M HEPES, 15%
PEG 4000, and 25% glycerol at pH 8.0. Attempts to obtain crystals of free
OspG were not successful.
Structure Determination
Diffraction data were collected at the CMCF-ID beamline at the Canadian Light
Source. Data were integrated and scaled with HKL3000 (Minor et al., 2006)
(Table 1). The structure was solved by molecular replacement with Phaser
(McCoy et al., 2007) using the UbcH7 structure first (PDB ID code 3SY2,
chain C) (Lin et al., 2012), then the NleH2 structure (PDB ID code 4LRK), and
next the Ub structure (PDB ID code 2KJH, chain B) (Serniwka and Shaw,
2009). Phenix_refine (Adams et al., 2011) and Coot (Emsley et al., 2010) were
used for iterativemodel refining and rebuilding. The pertinent details are shown
in Table 1.
Circular Dichroism
The circular dichroism spectra for OspG-WT, OspG-F154R, and OspG-L99R/
P102E were recorded using AppliedPhotophysics Chirascan-plus Circular
Dichroism Spectrometer. Prior to the assay, proteins were dialyzed against
10 mM Na-phosphate buffer (pH 7.5). The spectra were recorded in the range
of 180–260 nm at a protein concentration of 75 mg/ml.
In Vitro Kinase Activity Measurements
Wemeasured the kinase activity of OspG in vitro with [g-32P]ATP and histones
as an exogenous substrate using amodified protocol of Zhou et al. (2013). The
solution of OspG was dialyzed overnight against the reaction buffer to ensure
the absence of DTT in the sample. The 10 ml reactionmixtures contained 1.3 mg
of OspG and 5 mg of histone H1 preparation (Millipore) in 25 mM Tris-HCl
(pH 7.5), 10 mM MgCl2. Additionally 0.56 mg of Ub or 1.2 mg of UbcH7 or
1.8 mg of UbcH7-Ub were added to the reaction mixture, providing the final 1:1
molar ratio with OspG. In the case of OspG mutants, which showed reducedts reserved
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OspG Effector Kinase Bound to UbcH7Ub Conjugateactivity, 1.3 mg of OspG was premixed with 1.7 mg of Ub, 3.6 mg of UbcH7 or
5.4 mg of UbcH7-Ub, increasing the OspG-to-binding partner molar ratio to
1:3. The reactions were carried out for 1 hr at 28C and were started by addi-
tion of a mixture of ‘‘cold’’ ATP with [g-32P]ATP to a final concentration of
100 mM ATP and 2 mCi/reaction of [g-32P]ATP (3,000 Ci/mmol). Phosphoryla-
tion was monitored by imaging the radiolabeled proteins on nonreducing
SDS-PAGE usingMolecular Imager FX phosphorimager (Bio-Rad). The control
was the sample containing histone H1, OspG, UbcH7-Ub, and 10 mM EDTA
instead of Mg2+.
Ubiquitin Ligase Inhibition Assay
The ability of OspG to inhibit Ub transfer from E2 to E3 was monitored using an
autoubiquitination assay. Briefly, the ubiquitination of the C-terminal portion of
the human E3 ligase parkin (residues 77–465; DUblD) was monitored following
the published protocol (Chaugule et al., 2011) with some modifications. A
series of 25 mL reactions were set up using human recombinant E1 (15 nM),
UbcH7 (0.5 uM), His-tagged ubiquitin (5 uM), DUblD (1 mM), and 0–1 mM
OspG. A buffer containing 50 mM HEPES (pH 7.5), 5 mM MgCl2, and 5 mM
ATP was used. Reactions were incubated at 37C for 1 hr prior to quenching
with SDS-loading buffer containing DTT. Samples were run on 4%–15% tris-
glycine gels and transferred to polyvinylidene fluoride membranes. After treat-
ment with primary and secondary antibodies, the blots were imaged using an
Odyssey imaging instrument (LI-COR Biosciences) at 700 nm. Anti-His anti-
bodies were a generous gift from Dr. D. Litchfield (UWO). IRDye 680RD Goat
anti-Rabbit immunoglobulin G was from LI-COR Biosciences.
Expression of OspG in HEK293T Cells
The ospG coding sequence was previously cloned in the vector pRK5-Myc for
expression of OspG with an Myc-tag fused to its N terminus (Kim et al., 2005).
Mutations were introduced into the plasmid pRK5-myc-OspG to encode
OspG variants with L99R, P102E, L99R/P102E, and F154R replacements.
HEK293T cells were plated at 5 3 104 cells/well of a 12-well plate. Approxi-
mately 20 hr later, cells were transfected with 0.8 mg of pRK5-Myc (vector),
pRK5-Myc-OspG (WT OspG), or its derivatives encoding OspG variants
using Attractene transfection reagent (QIAGEN). At 40 hr posttransfection,
cells were, or not, treated with 10 mMMG132 (Sigma-Aldrich) for 3 hr. Samples
were recovered directly from plates in the reducing Laemli loading buffer (23),
boiled for 5 min, and sonicated during 10 s to shear the DNA. Samples were
loaded on 4%–20% gradient miniprotean gels (Bio-Rad) and analyzed by
immunoblotting using a polyclonal serum directed against the Myc epitope
(Santa Cruz, ref. sc-789).
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